By proceeding, you agree to our Terms of Use and Privacy Policy.
Amy Simon, M.D. is Chief Medical Officer of Beam Pharmaceuticals. Dr. Simon brings has over 20 years of clinical experience, serving in roles as a physician-scientist in academia and the biotechnology industry. Dr.
Talks About #clinicaldevelopment #drug #medicine
Preferred Locations #NorthAmerica
Recognised with a Nobel Prize in 2020, CRISPR has opened the floodgates for a new era of gene editing therapies, promising to transform genetic disease treatments.
